30.01.2013 Views

References

References

References

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

216 E.B. Blancaflor, K.D. Chapman<br />

14.5<br />

Conclusions and Future Prospects<br />

Since the discovery of anandamide as an endogenous neurotransmitter,<br />

there has been unprecedented progress in our understanding of NAE signaling<br />

in animals. As a result of these discoveries, new drugs have been<br />

designed that could potentially be used to treat medical conditions resulting<br />

from compromised endocannabinoid signaling (De Fonseca et al.<br />

2005). Although plant NAE research is still in its infancy, it appears that<br />

plants share many important features of animal endocannabinoid signaling<br />

(Fig. 14.2). For example, the accumulation of NAEs during pathogen<br />

elicitation and anoxic stress parallels the elevation of NAEs seen in mammalian<br />

cells undergoing neurological degeneration. Also there is evidence<br />

that plants, like animals, metabolize NAEs via amidohydrolase and LOX<br />

pathways. Finally, perception of NAE in plants may be facilitated by transmembrane<br />

proteins that could function in a manner analogous to the CB<br />

receptors in mammals. We anticipate that studies in this historically underpopulated<br />

field would be bolstered by new approaches such as lipid<br />

metabolic profiling (Saghatelian et al. 2004) and the more traditional forward/reverse<br />

genetic techniques to alter specific steps in NAE metabolism<br />

and perception. Moreover, the combination of sensitive quantitative procedures<br />

for endogenous NAE metabolites along with the identification of<br />

conditions that influence NAE accumulation should remain an important<br />

area of focus in the future.<br />

Acknowledgements. NAE research in the authors’ laboratories is supported<br />

by DOE (grant DE-FG02-05ER15647), USDA (grant NRICGP-99-35304–<br />

8002), the Noble Foundation and in part by NSF (grant DBI-0400580). We<br />

thankCharleneCaseforpreparingthefigures.<br />

<strong>References</strong><br />

Austin-Brown S, Chapman KD (2002) Inhibition of phospholipase Dα by Nacylethanolamines.<br />

Plant Physiol 129:1892–1898<br />

Bachur NR, Masek K, Melmon KL, Undenfriend S (1965) Fatty acid amides of ethanolamine<br />

in mammalian tissues. J Biol Chem 240:1019–1024<br />

Berdyshev EV, Schmid PC, Krebsbach RJ, Hillard CJ, Huang C, Chen N, Dong Z, Schmid<br />

HH (2001) Cannabinoid-receptor-independent cell signalling by N-acylethanolamines.<br />

Biochem J 360:67–75<br />

Berger C, Schmid PC, Schabitz WR, Wolf M, Schwab S, Schmid HHO (2004) Massive accumulation<br />

of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?<br />

J Neurochem 88:1159–1167

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!